日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

In vitro drug testing using patient-derived ovarian cancer organoids

使用患者来源的卵巢癌类器官进行体外药物测试

Lin-Yu Chen #, Yu-Ting Chou #, Phui-Ly Liew, Ling-Hui Chu, Kuo-Chang Wen, Shiou-Fu Lin, Yu-Chun Weng, Hui-Chen Wang, Po-Hsuan Su, Hung-Cheng Lai

Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor

活性 DNA 去甲基化酶 TET1 可增强卵巢癌干细胞对线粒体复合物 I 抑制剂的敏感性

Lin-Yu Chen, Yao-An Shen, Ling-Hui Chu, Po-Hsuan Su, Hui-Chen Wang, Yu-Chun Weng, Shiou-Fu Lin, Kuo-Chang Wen, Phui-Ly Liew, Hung-Cheng Lai

Clinical Efficacy of Polycaprolactone β-Calcium Triphosphate Composite for Osteoconduction in Rabbit Bone Defect Model

聚己内酯β-三磷酸钙复合材料对兔骨缺损模型骨传导的临床效果

Chiu-Ming Chen, Shen-Mao Chen, Shiou-Fu Lin, Huang-Chien Liang, Chia-Chun Wu

The MEK/ERK/miR-21 Signaling Is Critical in Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells

MEK/ERK/miR-21 信号传导对于 EGFR 突变型非小细胞肺癌细胞的奥希替尼耐药性至关重要

Wen-Chien Huang, Vijesh Kumar Yadav, Wei-Hong Cheng, Chun-Hua Wang, Ming-Shou Hsieh, Ting-Yi Huang, Shiou-Fu Lin, Chi-Tai Yeh, Kuang-Tai Kuo

Long Interspersed Nuclear Element 1 Retrotransposons Become Deregulated during the Development of Ovarian Cancer Precursor Lesions

长散在核因子 1 逆转录转座子在卵巢癌前病变发展过程中失调

Thomas R Pisanic 2nd, Shiho Asaka, Shiou-Fu Lin, Ting-Tai Yen, Hanru Sun, Asli Bahadirli-Talbott, Tza-Huei Wang, Kathleen H Burns, Tian-Li Wang, Ie-Ming Shih

Analysis of Telomere Lengths in p53 Signatures and Incidental Serous Tubal Intraepithelial Carcinomas Without Concurrent Ovarian Cancer

p53 标记和不伴有卵巢癌的偶发性浆液性输卵管上皮内癌的端粒长度分析

Shiho Asaka, Christine Davis, Shiou-Fu Lin, Tian-Li Wang, Christopher M Heaphy, Ie-Ming Shih